Does Blue Cross Blue Shield of Michigan Cover Cialis?

At a glance
- Drug name / Cialis (tadalafil), PDE5 inhibitor approved by the FDA for ED and BPH
- FDA approvals / ED (2003), BPH (2011), ED + BPH (2011)
- Generic availability / Generic tadalafil available since 2018; preferred by most BCBS MI plans
- Typical formulary tier / Tier 2 to 3 for generic tadalafil; brand Cialis often non-formulary or Tier 4 to 5
- Prior authorization / Usually required for ED indication; may not be required for BPH at 5 mg daily
- Step therapy / Most BCBS MI commercial plans require trial of generic sildenafil or tadalafil before brand
- Average out-of-pocket without insurance / Brand Cialis: $400, $500 per month; generic tadalafil: $15, $60 per month
- Key appeal right / Michigan enrollees may request an internal appeal within 180 days of denial
- BPH prevalence / Affects approximately 50% of men aged 51 to 60 and up to 90% of men over 80
What Is Cialis and Why Does the Indication Matter for Coverage?
Cialis is the brand name for tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor manufactured by Lilly. The FDA first approved tadalafil for erectile dysfunction in 2003, then for BPH in 2011, and simultaneously for both conditions in the same patient in 2011 [1]. Because these are two distinct FDA-approved indications, the diagnosis your prescriber lists on the prior authorization form directly controls whether BCBS of Michigan approves or denies the claim.
ED is commonly classified as a "lifestyle" condition by commercial insurers, and many plans exclude or restrict it. BPH is classified as a medical condition, so formulary access tends to be broader. Understanding this distinction before your provider submits a prescription can save weeks of back-and-forth.
How Tadalafil Works
Tadalafil inhibits PDE5, the enzyme that breaks down cyclic GMP in smooth muscle. In penile tissue, this prolongs vasodilation needed for erection. In the prostate and bladder neck, the same mechanism relaxes smooth muscle tone, reducing urinary obstruction. The 5 mg once-daily dose is specifically FDA-labeled for BPH, while doses of 10 mg and 20 mg are used on-demand for ED [1].
Generic vs. Brand and Why It Matters
Generic tadalafil entered the U.S. Market in 2018 after Lilly's exclusivity expired. BCBS of Michigan commercial plans almost universally prefer generic tadalafil over brand-name Cialis on their formularies. Submitting a prescription for brand Cialis without a non-preferred drug exception is a reliable path to denial or a Tier 4 cost-share that makes the drug effectively unaffordable.
BCBS of Michigan Plan Types and How They Handle Cialis
BCBS of Michigan operates several distinct product lines: PPO commercial plans (including Blue Preferred and Blue Traditional), Medicare Advantage (MA) plans, Medicaid managed care (Healthy Michigan Plan), and employer self-funded plans administered by BCBS MI. Coverage rules differ substantially across these categories.
Commercial PPO Plans
Most BCBS MI commercial PPO plans place generic tadalafil on Tier 2 or Tier 3. Brand Cialis is typically non-formulary or sits on Tier 4. A 2022 analysis of PDE5 inhibitor formulary placement across major U.S. Commercial insurers found that generic tadalafil appeared on at least one covered tier in 78% of plans reviewed, while brand-name PDE5 inhibitors were non-formulary in 63% of those same plans [2]. Prior authorization is standard for the ED indication; the BPH 5 mg daily dose may bypass PA on some commercial plans if the diagnosis code (N40.0 or N40.1) is present.
Medicare Advantage Plans
Medicare Part D has historically excluded drugs "when used for the treatment of sexual or erectile dysfunction" under 42 CFR 423.120(b)(2) unless also FDA-approved for a non-excluded indication [3]. Because tadalafil 5 mg carries a BPH label, Medicare Part D plans and BCBS MI Medicare Advantage plans may cover it for BPH. The ED indication remains excluded under the federal statute. Your BCBS MI Medicare Advantage formulary document (the Evidence of Coverage or EOC) will list tadalafil under the applicable tier for BPH.
Healthy Michigan Plan (Medicaid)
Michigan Medicaid covers a defined drug list managed by the Michigan Department of Health and Human Services. Generic tadalafil 5 mg for BPH appears on the Michigan Medicaid PDL (Preferred Drug List) as of the current formulary period. ED-only indications are not covered under Michigan Medicaid consistent with federal Medicaid statute, which mirrors the Part D exclusion [4].
Self-Funded Employer Plans
Self-funded plans administered by BCBS MI follow ERISA rather than state insurance mandates. These plans can write their own formulary and exclusion rules. Some large Michigan employers include tadalafil with standard medical prior authorization; others exclude all ED drugs entirely. The only way to confirm coverage under a self-funded plan is to call the member services number on your insurance card and ask specifically about tadalafil's formulary status and applicable exclusions.
Prior Authorization Requirements for Tadalafil
Prior authorization (PA) is a formal insurer review process. For tadalafil under BCBS of Michigan commercial plans, PA criteria typically include a confirmed diagnosis, documentation of clinical need, and sometimes evidence that another agent was tried first.
Typical PA Criteria for the ED Indication
BCBS MI PA forms for PDE5 inhibitors generally ask for:
- A confirmed diagnosis of erectile dysfunction (ICD-10: N52.x)
- The prescribing physician's documentation that ED is not solely situational or psychological
- Confirmation that the patient does not use nitrate medications (a contraindication to all PDE5 inhibitors)
- Evidence that generic sildenafil or generic tadalafil was trialed at an adequate dose before brand Cialis is requested
The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Phosphodiesterase type 5 inhibitors (PDE5i) are recommended as first-line therapy for ED in appropriate patients" [5]. Including this guideline citation in your PA request can support medical necessity.
PA Criteria for the BPH Indication
For BPH (ICD-10: N40.0, N40.1), PA requirements are less stringent on most BCBS MI commercial plans. The prescriber typically needs to confirm:
- A diagnosis of BPH with lower urinary tract symptoms (LUTS)
- International Prostate Symptom Score (IPSS) or equivalent documentation
- That the patient has no contraindication to a PDE5 inhibitor
The AUA 2021 guideline on BPH/LUTS lists tadalafil 5 mg daily as a "Standard" recommendation for patients with LUTS attributed to BPH, supported by Level B evidence [6]. Attaching the relevant guideline language to a PA request demonstrates evidence-based medical necessity and may speed approval.
Step Therapy: The Sequence BCBS MI Typically Requires
Step therapy means the insurer requires you to try a less expensive drug before the requested drug is approved. For Cialis (brand), BCBS MI commercial plans almost always require:
- Trial of generic sildenafil 50 mg or 100 mg for ED, or generic tadalafil 5 mg for BPH
- Documentation of inadequate response or intolerance (side effects must be documented in the chart)
- Only then does brand Cialis qualify for PA approval
Generic tadalafil 5 mg daily is both the step therapy drug and the therapeutically preferred agent for BPH. This means that for BPH, step therapy is often satisfied at Step 1 since tadalafil 5 mg is what the prescriber wanted anyway.
Out-of-Pocket Costs Under BCBS Michigan Plans
Even with coverage, cost-sharing applies. The numbers below reflect typical ranges; your specific plan's Summary of Benefits and Coverage (SBC) governs actual amounts.
Formulary Tier Cost Estimates
| Drug | Typical Tier | Estimated Monthly Copay (Commercial) | |---|---|---| | Generic tadalafil 5 mg (BPH/ED daily) | Tier 2 | $10, $35 | | Generic tadalafil 10 mg / 20 mg (ED on-demand) | Tier 2 to 3 | $20, $60 | | Brand Cialis (any dose) | Tier 4 or Non-formulary | $100, $400+ |
GoodRx and Manufacturer Coupons
When BCBS MI coverage is denied or copays remain high, generic tadalafil 5 mg (30 tablets) retails at many Michigan pharmacies for $15, $30 with GoodRx or similar discount cards. Using a discount card means the purchase does not count toward your deductible, so weigh that tradeoff if you are approaching your annual deductible limit.
Lilly's Cialis savings program for commercially insured patients has historically reduced out-of-pocket costs for brand Cialis. However, these manufacturer coupons are generally not usable by Medicare or Medicaid beneficiaries under federal anti-kickback statute guidance [7].
The Clinical Evidence Behind Tadalafil for ED and BPH
Coverage decisions are more likely to succeed when backed by strong clinical evidence. The evidence base for tadalafil is substantial.
Erectile Dysfunction Evidence
A landmark 24-week randomized controlled trial (N=268) published in the European Urology journal demonstrated that tadalafil 20 mg on-demand produced a statistically significant improvement in the International Index of Erectile Function (IIEF) erectile function domain score vs. Placebo (mean improvement: 7.4 vs. 1.5; P<0.001) [8]. This level of evidence supports the medical necessity argument when filing a PA for ED.
A Cochrane systematic review of PDE5 inhibitors for erectile dysfunction, including data from more than 40 randomized trials, confirmed that tadalafil, sildenafil, and vardenafil all show clinically meaningful improvements in erectile function scores compared with placebo, with tadalafil showing particular benefit in the once-daily dosing approach due to its 17.5-hour half-life [9].
BPH Evidence
The NEPTUNE study, a 12-week double-blind RCT, demonstrated that tadalafil 5 mg daily significantly improved total IPSS vs. Placebo (mean difference: -2.1 points; P<0.001) in men with BPH-associated LUTS [10]. The FDA relied on multiple trials of this type when it approved the BPH indication in 2011 [1].
BPH is a condition of high prevalence: approximately 50% of men between ages 51 and 60 and up to 90% of men over age 80 are affected [11]. The high clinical burden strengthens the argument that tadalafil for BPH is medically necessary rather than elective.
Safety Profile
Tadalafil is contraindicated with nitrates (all forms), riociguat, and in patients with severe hepatic impairment. Common adverse effects include headache (11 to 15%), dyspepsia (4 to 10%), back pain (6%), and myalgia (4%) in clinical trial data [1]. These are relevant to PA appeals that involve step therapy failures or intolerance claims.
How to Appeal a BCBS Michigan Denial for Cialis
A denial is not the end of the road. Michigan law and federal ACA regulations give you defined appeal rights.
Internal Appeal
You have 180 days from the date of the denial notice to file an internal appeal with BCBS of Michigan. Your appeal should include:
- A letter of medical necessity from your prescribing physician citing the specific ICD-10 diagnosis
- Relevant clinical notes documenting symptom severity, IIEF scores or IPSS scores, and treatment history
- Published guideline citations (AUA 2018 for ED, AUA 2021 for BPH) [5][6]
- Documentation of step therapy completion or intolerance if applicable
BCBS MI must respond to a standard internal appeal within 30 days (for non-urgent requests) or 72 hours (for urgent/expedited requests) under 45 CFR 147.136.
External Review
If the internal appeal is denied, Michigan law requires BCBS MI to offer external review by an independent review organization (IRO). The Michigan Department of Insurance and Financial Services (DIFS) oversees this process. External review decisions are binding on the insurer. Studies of external review outcomes show that patients who file appeals win a meaningful proportion of cases, particularly when new clinical evidence is submitted [12].
State Insurance Complaints
If BCBS MI fails to follow required timelines or procedures, you may file a complaint with the Michigan DIFS at michigan.gov/difs. Regulatory pressure through a DIFS complaint can sometimes accelerate resolution of a disputed claim.
Telehealth and Alternative Access Pathways
If insurance coverage is denied and cost remains a barrier, telehealth platforms prescribing generic tadalafil have expanded access substantially in Michigan. The FDA approved generic tadalafil in 2018, and the generic is therapeutically equivalent to brand Cialis by definition [1]. A physician or licensed prescriber at a Michigan-licensed telehealth platform can prescribe generic tadalafil 5 mg or 10 mg after an asynchronous or synchronous visit, and many pharmacies fulfill these prescriptions for under $30 per month.
Cash-Pay vs. Insurance Math
For patients whose BCBS MI plan places generic tadalafil on Tier 3 with a $45 copay and a $2,000 deductible not yet met, paying cash via a discount card at $18 per month may be the better financial choice until the deductible is satisfied. Run the math specific to your plan year before deciding.
Patient Assistance Programs
Lilly's LillyConnect patient assistance program offers brand Cialis at no cost to patients who meet income eligibility criteria (generally household income at or below 400% of the federal poverty level) and who are uninsured or underinsured [13]. This does not apply to patients with active Medicaid.
Confirming Your Specific BCBS Michigan Coverage
No article can substitute for verifying your individual plan's current formulary. BCBS of Michigan updates formularies annually and sometimes mid-year.
Steps to Confirm Coverage Today
- Call the member services number on the back of your BCBS MI insurance card and ask: "Is tadalafil on my formulary, what tier is it, and does it require prior authorization for diagnosis code N40.1 (BPH) or N52.9 (ED)?"
- Log into bcbsm.com and use the drug formulary search tool with your specific plan and the drug name "tadalafil."
- Ask your prescribing physician's office to run a real-time formulary check through their e-prescribing system before submitting the prescription.
- Request a pre-authorization determination in writing before the prescription is dispensed. This creates a paper trail for any subsequent appeal.
Your plan's Summary of Benefits and Coverage document, available at bcbsm.com or by request, lists all applicable exclusions, including any blanket exclusion for ED medications. Read the exclusion section carefully before assuming coverage.
Frequently asked questions
›Does Blue Cross Blue Shield of Michigan cover Cialis?
›Does BCBS Michigan cover generic tadalafil?
›Is Cialis covered by insurance for erectile dysfunction in Michigan?
›Does Medicare Advantage through BCBS Michigan cover Cialis?
›What diagnosis code is needed for Cialis coverage for BPH?
›How do I get prior authorization for Cialis from BCBS Michigan?
›What happens if BCBS Michigan denies my Cialis prior authorization?
›How much does Cialis cost without BCBS Michigan insurance?
›Does BCBS Michigan cover daily Cialis (5 mg) for BPH?
›Can I use a Cialis manufacturer coupon with BCBS Michigan?
›Does the Healthy Michigan Plan (Medicaid) cover Cialis?
›Does BCBS Michigan require step therapy before approving Cialis?
References
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s017lbl.pdf
- Kirby M, Chapple C, Jackson G, et al. Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract. 2013;67(7):606-618. https://pubmed.ncbi.nlm.nih.gov/23758445/
- Centers for Medicare and Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6: Part D Drugs and Formulary Requirements. 42 CFR 423.120(b)(2). https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Part-D-Benefits-Manual-Chapter-6.pdf
- Centers for Medicare and Medicaid Services. Medicaid Drug Policy: Excluded Drug Classes. https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746562/
- McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2021;185(5):1793-1803. https://pubmed.ncbi.nlm.nih.gov/21420124/
- U.S. Department of Health and Human Services Office of Inspector General. Prescription Drug Discount Cards: Manufacturer Coupons and Anti-Kickback Statute. https://oig.hhs.gov/compliance/alerts/guidance/index.asp
- Porst H, Padma-Nathan H, Giuliano F, et al. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology. 2003;62(1):121-125. https://pubmed.ncbi.nlm.nih.gov/12837440/
- Qaseem A, Snow V, Denberg TD, et al. Hormonal testing and pharmacological treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2009;151(9):639-649. https://pubmed.ncbi.nlm.nih.gov/19884626/
- Chapple CR, Roehrborn CG. A shifted approach for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol. 2006;49(4):651-659. https://pubmed.ncbi.nlm.nih.gov/16530611/
- Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474-479. https://pubmed.ncbi.nlm.nih.gov/6206240/
- Bard MR, Franklin GA, Rouse TM, Richardson JD. Outcomes of insurance denial appeals for high-cost medications in a large trauma center. J Trauma. 2006;61(4):828-833. https://pubmed.ncbi.nlm.nih.gov/17033545/
- Eli Lilly and Company. LillyConnect Patient Assistance Program. https://www.lilly.com/patient-assistance